ende

Because medical advances need a strong partner.

Funding is limited, especially for research projects in the area of Investigator Initiated Trials (IITs). But often there are interesting non-commercial studies that are essential for clinical research and for the further development and improvement of existing therapy concepts in day-to-day clinical practice – and in particular for the optimisation of patient treatment.

Regulatory requirements and the number of involved partners mean that research projects are becoming increasingly complex. At the IKF, we offer you the “space” for your research, link you up with relevant academic partners, and help you to stay in control during the research process. At every important step. With the organisation, the data, the workload, funding issues, the administration and the application process.

What we offer

    • Identification of anticipated costs and funding requirements
    • Financing and securing funding – in particular through applications for third-party funding and earmarked donations
    • Application for approvals and ethics committee opinions
    • Contract and project management as well as study coordination and controlling in line with the provisions of Good Clinical Practice (GCP), under the AMG [German Medicinal Products Act], the MPG [German Medical Devices Act] and professional law
    • Assistance with the statistical evaluation
    • Ensuring the best possible data quality and patient safety
    • Scientific supervision and support by our Advisory Board

Current research projects

The process of statistical consultancy and presentation, as well as evaluation of your research project:

1.
Give us an outline of your research idea.

2.
Together, we will formulate the specifics of your project and create the funding plan.

3.
We will support you in applying for approvals and ethics committee opinions.

4.
You start your research.

Publications

Filters
Reset
Reset
Reset

Metabolomics analysis reveals novel serum metabolite alterations in cancer cachexia.

Authors: More TH, Hiller K, Seifert M, Illig T, Schmidt R, Gronauer R, von Hahn T, Weilert H, Stang A.
Journal: Front Oncol. 2024 Feb 20;14:1286896.

Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes.

Authors: Lange F, Garn J, Anagho HA, Vondran FWR, von Hahn T, Pietschmann T, Carpentier A.
Journal: Liver Int. 2023 Oct;43(10):2116-2129.

Predictive Factors for the Outcome of Unsupervised Endoscopic Submucosal Dissection During the Initial Learning Curve with Prevalence-Based Indication.

Authors: Steinbrück I, Faiss S, Dumoulin FL, Oyama T, Pohl J, von Hahn T, Schmidt A, Allgaier HP.
Journal: Dig Dis Sci. 2023 Sep;68(9):3614-3624.

Learning curve of endoscopic submucosal dissection (ESD) with prevalence-based indication in unsupervised Western settings: a retrospective multicenter analysis

Authors: Steinbrück I, Faiss S, Dumoulin FL, Oyama T, Pohl J, von Hahn T, Schmidt A, Allgaier HP.
Journal: Surg Endosc. 2023 Apr;37(4):2574-2586